"This is the type of collaboration that becomes possible with new diagnostic tools to help therapeutic interventions in AD. The mechanisms involved may begin to validate emerging targets in the field of AD, and I am excited to help bring this collaboration forward," commented Robert A. Stern, Ph.D.,
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links